Breakthrough Phase-III results for next-generation GLP-1 obesity drugs have injected fresh momentum into the MSCI World Health Care Index. Traders have dubbed this the MSCI healthcare GLP-1 rally. With the index up 9 percent in just eight trading sessions, investors…
While gene-therapy approvals advance, the MSCI World Health Care Index is rallying. Therefore, investors are reassessing healthcare index performance and long-term growth prospects in the sector. 1. Gene-Therapy Approvals Drive Sector Optimism First, breakthrough FDA and EMA approvals for next-generation…
Tracks the health-care constituents of the S&P 500—pharmaceuticals, biotech, medical devices and managed-care firms—therefore giving investors a concentrated, large-cap view of America’s most defensive growth industry. 1. Why This Index Exists To begin with, the S&P Dow Jones index family…
A sector-specific benchmark that bundles large- and mid-cap health-care companies from 23 developed markets, thereby offering investors a single, globally diversified snapshot of everything from blockbuster drugmakers to cutting-edge medical-device suppliers. 1. Why the Index Matters First and foremost, health-care…
Benchmarks that carve global markets into drugmakers, medical-device innovators, biotech researchers and healthcare-service providers—thus enabling investors to track, compare, and allocate capital to one of the world’s most defensive, yet constantly innovating, industries. 1. Why Healthcare Gets Its Own Indices…